TCRT ALAUNOS THERAPEUTICS INC Delisting Actions 8-K Filing 2023 - Voluntary Delisting Alaunos Therapeutics, Inc. has been notified by the Nasdaq Stock Market that its common stock's bid price has been failing the minimum requirement of $1.00 per share for the last 30 business days. Given 180 days to comply, the company has applied to transfer the listing of its common stock from Nasdaq Global Select Market to the Nasdaq Capital Market, has been approved and has received an extended compliance period till January 2, 2024.Get access to all SEC 8-K filings of the ALAUNOS THERAPEUTICS INC